UNSPSC 51201629: Diphtheria and tetanus toxoids absorbed

This clasification denotes a compound preparation. The first component of this preparation addresses a localized infection of mucous membranes or skin caused by toxigenic strains of corynebacterium diphtheriae characterized by the presence of a pseudomembrane at the site of infection. diphtheria toxin, produced by C. diphtheriae, can cause myocarditis, polyneuritis, and other systemic toxic effects. The second component of this preparation addresses a disease caused by tetanospasmin, a powerful protein toxin produced by CLOSTRIDIUM TETANI.

Tetanus usually occurs after an acute injury, such as a puncture wound or laceration. Generalized tetanus, the most common form, is characterized by tetanic muscular contractions and hyperreflexia.

UNSPSC 51201629 Diphtheria and tetanus toxoids absorbed is a Commodity code that state and local health departments use to procure vaccines and immunological products for public health programs and disease prevention. Based on recent solicitation activity, the code encompasses both routine immunization inventory and specialized vaccine procurement. The issuing bodies are state health departments, which manage vaccination programs, disease surveillance, and public health emergency preparedness at the state level. These agencies solicit under the code to maintain stockpiles for routine immunizations, respond to outbreak conditions, and fulfill statutory vaccination requirements for school enrollment and occupational health.

Recent solicitation activity shows minimal direct purchasing under this code. The Mississippi State Department of Health posted a sole source procurement notice (3150006922, due August 3, 2026) for Yellow Fever Vaccine from Sanofi Pasteur, Inc., though this opportunity is taxonomically misaligned with the diphtheria and tetanus toxoids absorbed code and represents a different vaccine product line. No recent opportunities for diphtheria and tetanus toxoids specifically appear in the available record. State health departments conducting routine immunization procurement typically issue these solicitations through RFQ or IFB processes with extended response windows, often leveraging cooperative purchasing agreements or state contracts to manage volume and pricing. The code shows limited recent transparent activity in the state and local procurement marketplace, suggesting either ongoing reliance on standing state contracts, cooperative purchasing vehicles, or procurement conducted outside public notice channels.